Compare Illumina, Inc. (ILMN) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs JetBlue Airways Corporation — how do they compare? Illumina, Inc. trades at $264.24 (market cap $40.43B), while JetBlue Airways Corporation trades at $3.92 (market cap $1.48B). The key difference: Illumina, Inc. is far larger — about 27.3× JetBlue Airways Corporation's market cap, and Illumina, Inc. is trading nearer its 52-week high, JetBlue Airways Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and JetBlue Airways Corporation for 44 Days on average.
| ILMN | JBLU | |
|---|---|---|
Market Cap | $40.43B | $1.48B |
Volume | 2,948,626 | 30,275,693 |
Sector | Health | Industrials |
52-Week High | $293.69 | $6.46 |
52-Week Low | $91.00 | $3.92 |
Typical Hold Time | 83 Days | 44 Days |
Enterprise Value | $41.79B | $8.84B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
JetBlue (JBLU) trades at $3.97, down 1.49% on the day, with the stock showing bearish technical momentum despite trading near its 52-week low. The company continues to face fundamental challenges with negative net income margins (-9.32% in 2025) and declining revenue trends, though valuation metrics like P/S (0.15) and P/B (0.94) appear attractive. Recent developments include route expansion to Colombia and the launch of BlueFirst premium seating, while activist investor Carl Icahn recently exited board positions per the 2024 agreement.
The outlook remains challenging with persistent losses and high debt levels (debt-to-asset ratio over 50%), though analyst consensus targets $5.89 suggesting potential upside. Key risks include elevated fuel costs, competitive pressures, and ongoing negative cash flow from operations. Investment opportunity exists for value investors betting on operational turnaround, but requires careful risk management given the company's financial strain.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
